POLARIS GROUP - Key Persons
Job Titles:
- Senior Vice President, Clinical Affairs
Amanda Johnston joined Polaris in 2010 bringing with her 20 years of drug development experience in the pharmaceutical industry.
She spent over 10 years at Agouron Pharmaceuticals Inc., Warner-Lambert and Pfizer, where she led clinical and interdisciplinary project teams for oncology and ophthalmology drug candidates. Subsequently, she launched a consulting business that provided drug development services to pharmaceutical and biotech companies.
Her experience encompasses drug development programs in oncology, ophthalmology, CNS and infectious disease.
Dr. Johnston earned her Ph.D. in Pharmacology from the School of Pharmacy, University of London.
Job Titles:
- Chairman of the Compensation Committee
- Independent Director
- Member of the Operational Situation of Compensation Committee
Job Titles:
- Senior Vice President, Operations
Job Titles:
- Chairman
- Chief Executive Officer
- Member of the Board
- Representative
Job Titles:
- Executive Vice President, Medical Affairs
Job Titles:
- Senior Vice President, Production & Process Development
Liang joined Polaris Pharmaceuticals in 2003 since the initial establishment of the Vacaville site. He has been leading the technology transfer, process development/scale-up, and continuous process improvement. Serving as a member of the site management team to plan and coordinate the inter-department activities, he participates in the execution of production strategies and oversees the operation schedules for cGMP manufacturing, in support of the multiple ongoing clinical trials.
Prior to joining Polaris, Liang had been engaging in various medical research projects on human diseases for over 15 years.
Liang holds an M.D. from the Shanghai Medical College, Fudan University (formerly the independent Shanghai Medical University), and a Ph.D. in molecular biology and microbiology from the Case Western Reserve University Biomedical Science Training Program. He completed his postdoctoral training at the UC Davis Cancer Center.
Dr. Chen spent more than 26 years with the U.S. Food and Drug Administration in new drug development as a primary/supervisory medical staff, holding the role of Deputy Director, Office of Drug Evaluation, Center for Drug Evaluation and Research.
His achievements included management of new drug review divisions, drafting and implementing FDA guidance for new class drug products and establishing modern drug review agency, as well as educating and training regulatory scientists in the Asian Pacific region.
Dr. Chen received his M.D. from the University of Miami and his Ph.D. in Biophysics from Johns Hopkins University.
He completed post-graduate training at Johns Hopkins, Yale University, the University of Minnesota, and the U.S. National Institutes of Health.
Dr. Chen has authored numerous basic science and clinical papers, as well as drug regulatory guidance publications.
Job Titles:
- Independent Director
- Member of the Compensation Committee
- Member of the Operational Situation of Compensation Committee
Job Titles:
- Member of the Board
- Representative
Job Titles:
- Member of the Compensation Committee
- Member of the Operational Situation of Compensation Committee